Volume 45, Issue 5 pp. 297-303

Varicella immunisation practice: Implications for provision of a recommended, non-funded vaccine

Helen Marshall

Corresponding Author

Helen Marshall

Department of Paediatrics, Women's and Children's Hospital,

Discipline of Public Health, School of Population Health and Clinical Practice,

Discipline of Paediatrics, School of Paediatrics and Reproductive Medicine,

Dr Helen Marshall, Discipline of Paediatrics, School of Paediatrics and Reproductive Medicine, Women's and Children's Hospital, 72 King William Road, North Adelaide, SA 5006, Australia. Fax: +61 8 8161 7031; email: [email protected]Search for more papers by this author
Philip Ryan

Philip Ryan

Discipline of Public Health, School of Population Health and Clinical Practice,

Search for more papers by this author
Don Roberton

Don Roberton

Division of Health Sciences, University of Otago, Dunedin, New Zealand

Search for more papers by this author
Justin Beilby

Justin Beilby

Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia, Australia and

Search for more papers by this author
First published: 28 April 2009
Citations: 18

Abstract

Aim:  In Australia in 2003 a two-tiered immunisation schedule was introduced consisting of funded (National Immunisation Program) and non-funded but recommended vaccines (Best Practice Schedule), including varicella vaccine. The aim of this study was to examine immunisation practice when a vaccine is recommended but not funded by Government.

Methods:  A survey was sent to 600 randomly selected general practitioners (GPs) in South Australia between June and August 2005, prior to provision of Federal funding for varicella vaccine.

Results:  Although varicella was considered an important disease to prevent by 89% of GPs, only 25% of GPs always discussed the non-funded immunisation with parents at the time of a routine immunisation visit. Female GPs were more likely to discuss immunisation with recommended, non-funded vaccines than male GPs. Those who were supportive of varicella prevention were more likely to discuss immunisation with the non-funded vaccine. GPs who always provided information about the disease were more likely to have parents accept their advice about varicella vaccine (62.7%) than those who never provided information (40%). GPs reported parental refusal of varicella vaccine was due to the cost and perception that varicella is a mild disease.

Conclusions:  The results of this study showed variability in prescribing practices for a non-funded vaccine. Recommending a vaccine without provision of funding may lead to ‘mixed messages’ for immunisation providers and parents with resultant low coverage. Funding a vaccine is likely to reduce variability in provision of the vaccine and improve coverage in the community.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.